Starting March 1, 2025, Covid-19 tests conducted in pharmacies will no longer be covered by France’s national health insurance, according to a decree published in the Official Journal on February 22. This marks the end of an era where antigen and PCR tests were fully reimbursed by the Assurance Maladie, costing approximately €16.50 per test, as reported by the government website Service Public.
However, certain exceptions will remain in place. Vulnerable individuals, including those with pre-existing health conditions, the elderly, and patients with long-term illnesses, will continue to receive reimbursement for tests if prescribed by a doctor. For the general public, the cost of testing will now fall on individuals.
For those seeking alternatives, self-tests remain an accessible option. While not reimbursed, these tests are available over the counter in pharmacies for around €3 to €4 each. They provide a quick and relatively reliable method for detecting the virus. In cases of uncertainty or specific health concerns, consulting a general practitioner is recommended.
This decision, made by the Ministry of Health, aligns with the gradual phasing out of crisis measures introduced during the pandemic. Since October 2021, so-called “comfort tests” for non-essential purposes had already ceased to be reimbursed, though they remained free in certain circumstances.
The move reflects a broader shift as France transitions from emergency pandemic protocols to a more normalized healthcare approach. As the country adapts to living with Covid-19, the focus now turns to balancing public health needs with financial sustainability.
